PSOREAL Trademark

Trademark Overview


On Tuesday, June 7, 2016, a trademark application was filed for PSOREAL with the United States Patent and Trademark Office. The USPTO has given the PSOREAL trademark a serial number of 79198733. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, May 3, 2024. This trademark is owned by LEO Pharma A/S. The PSOREAL trademark is filed in the Education & Entertainment Services and Computer & Software Services & Scientific Services categories with the following description:

Educational services, namely, conducting classes, seminars and workshops in the field of cancer and dermatological, hematological, renal and endocrine disorders; education services, namely, providing on-line classes, seminars, and workshops in the field of cancer and dermatological, hematological, renal and endocrine disorders; organizing events for educational purposes in the field of pharmaceutical and medical products; providing on-line non-downloadable electronic publications, namely, books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders; publication of electronic books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders; ...

Development of pharmaceutical preparations and medicines; pharmaceutical research services; medical research services in the field of cancer and dermatological, hematological, renal and endocrine disorders; conducting clinical trials for others for pharmaceutical products in the field of cancer and dermatological, hematological, renal and endocrine disorders; providing information in the field of cancer and dermatological, hematological, renal and endocrine disorders about the results of clinical trials for pharmaceutical products; providing temporary use of online software applications containing information on the use of pharmaceutical products and for calculating use of medicine
psoreal

General Information


Serial Number79198733
Word MarkPSOREAL
Filing DateTuesday, June 7, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, May 3, 2024
Registration Number5308840
Registration DateTuesday, October 17, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 1, 2017

Trademark Statements


Goods and ServicesEducational services, namely, conducting classes, seminars and workshops in the field of cancer and dermatological, hematological, renal and endocrine disorders; education services, namely, providing on-line classes, seminars, and workshops in the field of cancer and dermatological, hematological, renal and endocrine disorders; organizing events for educational purposes in the field of pharmaceutical and medical products; providing on-line non-downloadable electronic publications, namely, books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders; publication of electronic books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and dermatological, hematological, renal and endocrine disorders; entertainment services, namely, providing online electronic educational and informational games in the field of cancer and dermatological, hematological, renal and endocrine disorders and the treatment thereof
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; pharmaceutical research services; medical research services in the field of cancer and dermatological, hematological, renal and endocrine disorders; conducting clinical trials for others for pharmaceutical products in the field of cancer and dermatological, hematological, renal and endocrine disorders; providing information in the field of cancer and dermatological, hematological, renal and endocrine disorders about the results of clinical trials for pharmaceutical products; providing temporary use of online software applications containing information on the use of pharmaceutical products and for calculating use of medicine

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 3, 2024
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 3, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLEO Pharma A/S
Party Type30 - Original Registrant
Legal Entity Type84 - NOT AVAILABLE
AddressDK

Party NameLEO Pharma A/S
Party Type20 - Owner at Publication
Legal Entity Type84 - NOT AVAILABLE
AddressDK

Party NameLEO Pharma A/S
Party Type10 - Original Applicant
Legal Entity Type84 - NOT AVAILABLE
AddressDK

Trademark Events


Event DateEvent Description
Thursday, December 22, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, December 27, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 27, 2016ASSIGNED TO EXAMINER
Saturday, December 31, 2016APPLICATION FILING RECEIPT MAILED
Tuesday, January 17, 2017NON-FINAL ACTION WRITTEN
Wednesday, January 18, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 19, 2017REFUSAL PROCESSED BY MPU
Thursday, January 19, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 3, 2017REFUSAL PROCESSED BY IB
Wednesday, February 22, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 22, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 22, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 13, 2017NON-FINAL ACTION WRITTEN
Monday, March 13, 2017NON-FINAL ACTION MAILED
Thursday, March 30, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 8, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 1, 2017FINAL REFUSAL WRITTEN
Thursday, March 30, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 30, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 25, 2017NON-FINAL ACTION WRITTEN
Wednesday, April 26, 2017NON-FINAL ACTION MAILED
Monday, May 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 2, 2017FINAL REFUSAL MAILED
Monday, June 12, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, July 12, 2017NOTICE OF PUBLICATION
Tuesday, August 1, 2017PUBLISHED FOR OPPOSITION
Friday, September 1, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 17, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, January 17, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, January 26, 2018FINAL DISPOSITION PROCESSED
Monday, June 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 14, 2017REFUSAL PROCESSED BY IB
Friday, September 1, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 17, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, May 3, 2024CANCELLED SECTION 71
Saturday, May 21, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, January 26, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 16, 2018FINAL DECISION TRANSACTION PROCESSED BY IB